Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

TARA - Protara Therapeutics, Inc. Financial... | Finranks

Home

/

TARA

P

Protara Therapeutics, Inc. (TARA)

NGM – Real Time Price. Currency in USD

3.90

-0.01 (-0.26%)

Market open: Aug 12, 2026, 11:14 AM EDT

3.96

+0.05 (1.28%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

0

0

0

Cost of goods sold

-362K

-332K

-341K

-247K

Gross Profit

-362K

-332K

-341K

-247K

Operating expenses (excl. COGS)

-64M

-49M

-43M

-37M

Operating Income

-65M

-49M

-44M

-38M

Non-operating income, total

7M

5M

3M

-28M

Pretax income

-57M

-45M

-40M

-66M

Equity in earnings

0

0

0

0

Taxes

0

0

0

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-57M

-45M

-40M

-66M

Discontinued operations

0

0

0

0

Net income

-57M

-45M

-40M

-66M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

209M+15.4%

181M+129.8%

79M-30.3%

113M

Total current assets

160M

172M

69M

86M

Total non-current assets

50M

9M

10M

27M

Total liabilities

13M-8.8%

14M+34.7%

11M-5.1%

11M

Total current liabilities

11M

11M

6M

6M

Total non-current liabilities

2M

3M

4M

5M

Total equity

196M

167M

68M

102M

Total liabilities & shareholders' equities

209M

181M

79M

113M

Total debt

3M-25.1%

4M-18.0%

5M-14.4%

6M

Name

2025

2024

2023

2022

Cash from operating activities

-56M

-36M

-38M

-26M

Cash from investing activities

-139M

19M

53M

15M

Cash from financing activities

83M

140M

-91K

-90K

Free cash flow

-56M-57.4%

-36M+4.6%

-38M-41.5%

-27M